Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran.
Department of Biotechnology, Faculty of Biological Science and Technology, University of Isfahan, Isfahan, Iran.
Front Cell Infect Microbiol. 2022 Aug 3;12:921410. doi: 10.3389/fcimb.2022.921410. eCollection 2022.
() species are protozoan parasites with a complex life cycle consisting of a number of developmental forms that alternate between the sand fly vector and their host. The non-pathogenic species is not able to induce an active infection in a human host. It has been observed that, in pathogenic species, extracellular vesicles (EVs) could exacerbate the infection. However, so far, there is no report on the identification, isolation, and characterization of EVs. In this study, we have isolated and characterized EVs from (tEVs) along with as a reference and positive control. The EVs secreted by these two species demonstrated similar particle size distribution (approximately 200 nm) in scanning electron microscopy and nanoparticle tracking analysis. Moreover, the said EVs showed similar protein content, and GFP and GP63 proteins were detected in both using dot blot analysis. Furthermore, we could detect -derived GP63 protein in THP-1 cells treated with tEVs. Interestingly, we observed a significant increase in the production of IFN-γ, TNF-α, and IL-1β, while there were no significant differences in IL-6 levels in THP-1 cells treated with tEVs following an infection with compared with another group of macrophages that were treated with EVs prior to the infection. Another exciting observation of this study was a significant decrease in parasite load in tEV-treated -infected macrophages. In addition, in comparison with another group of -infected macrophages which was not exposed to any EVs, tEV managed to increase IFN-γ and decrease IL-6 and the parasite burden. In conclusion, we report for the first time that can release EVs and provide evidence that tEVs are able to control the infection in human macrophages, making them a great potential platform for drug delivery, at least for parasitic infections.
()属原生动物寄生虫,具有复杂的生命周期,包括在沙蝇媒介和宿主之间交替的几种发育形式。非致病性 不能在人类宿主中引起主动感染。已经观察到,在致病性物种中,细胞外囊泡(EVs)可能会加剧感染。然而,到目前为止,还没有关于 的鉴定、分离和特征描述的报道。在这项研究中,我们从 (tEVs)中分离并鉴定了 EVs, 作为参考和阳性对照。这两种物种分泌的 EVs 在扫描电子显微镜和纳米颗粒跟踪分析中表现出相似的粒径分布(约 200nm)。此外,所述 EVs 表现出相似的蛋白质含量,并且使用斑点印迹分析在两者中均检测到 GFP 和 GP63 蛋白。此外,我们可以在用 tEVs 处理的 THP-1 细胞中检测到 衍生的 GP63 蛋白。有趣的是,与另一组在用 感染之前用 EVs 处理的巨噬细胞相比,用 tEVs 处理的 THP-1 细胞中观察到 IFN-γ、TNF-α 和 IL-1β 的产生显著增加,而 IL-6 水平没有显著差异。这项研究的另一个令人兴奋的观察结果是,在用 tEVs 处理的感染 的巨噬细胞中寄生虫负荷显著降低。此外,与另一组未接触任何 EVs 的感染 的巨噬细胞相比,tEV 设法增加 IFN-γ 并降低 IL-6 和寄生虫负担。总之,我们首次报道 可以释放 EVs,并提供证据表明 tEVs 能够控制人类巨噬细胞中的感染,使它们成为药物输送的巨大潜在平台,至少对于寄生虫感染而言。